TP53 and breast cancer: GO and KEGG enrichment analysis revealed that the DEGs were mostly linked to EMT, transcriptional activation of cell cycle inhibitor p21 and transcriptional activation of p53 responsive genes, indicating a regulatory role of METTL3 in the progression of HR+HER2− BC (Fig. 5B, C).